海尔生物
(688139)
| 流通市值：104.03亿 | | | 总市值：104.03亿 |
| 流通股本：3.18亿 | | | 总股本：3.18亿 |
| 报告期 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 901,227,075.69 | 983,791,234.62 | 1,151,899,865.06 | 1,319,514,483.34 |
| 应收票据及应收账款 | 330,991,696.12 | 447,310,936.31 | 393,451,647.22 | 340,725,221.09 |
| 其中：应收票据 | 7,145,875.33 | 7,350,475.79 | 1,708,273.56 | 6,016,861.79 |
| 应收账款 | 323,845,820.79 | 439,960,460.52 | 391,743,373.66 | 334,708,359.3 |
| 应收款项融资 | 12,418,141.22 | 446,407.8 | 9,989,221.36 | 7,956,020.69 |
| 预付款项 | 27,267,096.16 | 19,950,887.63 | 19,290,706.62 | 13,757,238 |
| 其他应收款合计 | 8,556,956.91 | 8,234,663.14 | 9,301,742.7 | 7,317,947.58 |
| 存货 | 334,744,974.95 | 258,026,061.32 | 244,993,394.53 | 250,844,999.65 |
| 合同资产 | 9,348,923.99 | 5,205,741.83 | 1,789,666.34 | - |
| 一年内到期的非流动资产 | 126,539,483.63 | 51,825,683.8 | 151,235,412.36 | 109,003,194 |
| 其他流动资产 | 24,103,642.14 | 19,853,470.35 | 21,158,796.47 | 18,167,125.78 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,652,447,941.35 | 2,660,812,428.8 | 2,405,604,989.66 | 2,748,960,813.13 |
| 非流动资产: | | | | |
| 长期股权投资 | 137,987,031.94 | 134,806,348.12 | 133,181,471.47 | 131,295,622.38 |
| 其他权益工具投资 | 41,397,596.47 | 28,199,861.65 | 28,199,861.65 | 56,878,493.06 |
| 其他非流动金融资产 | 9,000,000 | 9,000,000 | 9,000,000 | 9,000,000 |
| 投资性房地产 | 8,857,663.47 | 9,045,063.75 | 9,241,985.97 | 9,429,386.25 |
| 固定资产 | 807,291,286.02 | 802,356,927.99 | 810,585,608.69 | 773,513,479.24 |
| 在建工程 | 95,034,029.25 | 96,950,701.65 | 77,351,106.94 | 87,817,966.53 |
| 使用权资产 | 12,854,331.79 | 14,016,749.21 | 12,539,069.54 | 11,326,751.64 |
| 无形资产 | 402,302,641.03 | 413,962,989.63 | 425,371,371.98 | 357,703,925.55 |
| 商誉 | 757,866,205.38 | 758,169,731.51 | 757,755,028.67 | 642,629,062.25 |
| 长期待摊费用 | 6,715,706 | 6,516,454.13 | 6,713,900.47 | 5,325,477.72 |
| 递延所得税资产 | 66,008,575.05 | 62,490,424.74 | 62,592,740.56 | 57,658,178.38 |
| 其他非流动资产 | 789,705,787.26 | 645,367,055.64 | 848,584,539.19 | 795,296,473.02 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 3,135,020,853.66 | 2,980,882,308.02 | 3,181,116,685.13 | 2,937,874,816.02 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 5,787,468,795.01 | 5,641,694,736.82 | 5,586,721,674.79 | 5,686,835,629.15 |
| 流动负债: | | | | |
| 短期借款 | 10,009,027.78 | 19,096,331.82 | 21,104,670.4 | 11,010,694.44 |
| 应付票据及应付账款 | 427,598,354.67 | 434,231,479.44 | 423,326,041.66 | 497,253,159.53 |
| 其中：应付票据 | 90,192,201.48 | 102,814,580.99 | 110,535,492.82 | 104,007,097.3 |
| 应付账款 | 337,406,153.19 | 331,416,898.45 | 312,790,548.84 | 393,246,062.23 |
| 合同负债 | 151,984,833.74 | 61,621,731.09 | 55,794,947.72 | 59,586,370.75 |
| 应付职工薪酬 | 83,940,305.47 | 82,845,494.45 | 73,356,340.12 | 66,094,252.55 |
| 应交税费 | 50,913,525.45 | 51,236,833.51 | 51,768,970.32 | 64,557,301.27 |
| 其他应付款合计 | 273,354,626.83 | 276,454,629.34 | 289,181,966.93 | 266,856,315.76 |
| 一年内到期的非流动负债 | 13,204,768.63 | 17,396,747.19 | 15,954,925.15 | 14,524,820.47 |
| 其他流动负债 | 11,398,099.94 | 5,958,435.7 | 6,144,161.86 | 8,006,980.03 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,022,403,542.51 | 948,841,682.54 | 936,632,024.16 | 987,889,894.8 |
| 非流动负债: | | | | |
| 租赁负债 | 7,432,212.61 | 8,766,942.32 | 7,597,964.98 | 8,731,659.79 |
| 长期应付款 | 55,252,585.16 | 54,607,357.16 | 53,962,129.16 | 53,316,901.16 |
| 预计负债 | 8,560,784.75 | 5,596,795.14 | 5,596,795.14 | 7,080,650.72 |
| 递延收益 | 23,168,795.89 | 27,328,207.18 | 28,536,368.41 | 27,890,529.8 |
| 递延所得税负债 | 52,514,841.3 | 55,078,023.9 | 56,829,367.66 | 45,428,856.27 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 146,929,219.71 | 151,377,325.7 | 152,522,625.35 | 142,448,597.74 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,169,332,762.22 | 1,100,219,008.24 | 1,089,154,649.51 | 1,130,338,492.54 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 317,952,508 | 317,952,508 | 317,952,508 | 317,952,508 |
| 资本公积 | 1,977,335,357.14 | 1,975,507,012.43 | 1,989,000,700.16 | 1,987,038,000.41 |
| 减:库存股 | 140,197,717.52 | 140,197,717.52 | 125,409,937.49 | 125,243,041.7 |
| 其他综合收益 | -2,693,310.15 | -13,291,752.57 | -14,079,617.69 | 10,385,264.27 |
| 盈余公积 | 158,976,254 | 158,976,254 | 158,976,254 | 158,976,254 |
| 未分配利润 | 2,060,177,419.54 | 2,002,686,468.81 | 1,927,887,457.5 | 1,993,733,132.08 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 4,371,550,511.01 | 4,301,632,773.15 | 4,254,327,364.48 | 4,342,842,117.06 |
| 少数股东权益 | 246,585,521.78 | 239,842,955.43 | 243,239,660.8 | 213,655,019.55 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 4,618,136,032.79 | 4,541,475,728.58 | 4,497,567,025.28 | 4,556,497,136.61 |
| 负债和股东权益合计 | 5,787,468,795.01 | 5,641,694,736.82 | 5,586,721,674.79 | 5,686,835,629.15 |
| 公告日期 | 2025-03-29 | 2024-10-30 | 2024-08-23 | 2024-04-26 |
| 审计意见(境内) | 标准无保留意见 | | | |